Press
Quick Question January 2026 Result:
The highest response was access to specialists with FTD experience with 20.4%. There was also strong support for emotional or mental health support for patient and/or caregiver at 15.2% and …
Read MoreYou Joined. Now What? Five Small Ways to Stay Research Ready
You joined the FTD Disorders Registry. Now learn five simple ways to stay research ready and strengthen the future of FTD research.
Read MorePrevail Therapeutics PR006 Trial Discontinued
While the PR006 program has been discontinued, research into FTD continues. Here’s what this update means for the community and the path forward.
Read MoreWhat Makes a Registry “Research Ready”?
What does it really mean for an FTD registry to be research ready, and why does community participation matter so much?
Read MoreStrengthening FTD Research with CureGRN
Progress toward an FTD cure depends on communities and researchers working together.
Read MoreQuick Question December 2025 Result:
712 people responded and your responses are already helping us deepen scientific understanding of this symptom and will contribute directly to future research.
Read MoreA Year of Growth and Impact: 2025 at the FTD Disorders Registry
As 2025 comes to a close, we reflect on a year of growth and engagement that underscores the FTD Disorders Registry’s role in advancing research and amplifying the voices of those impacted by FTD.
Read MoreFTD Disorders Registry Research at CTAD 2025
The FTD Disorders Registry was featured at CTAD in San Diego, where a poster presented by Dr. Shana Dodge highlighted how the Registry is helping accelerate clinical trial recruitment in frontotemporal degeneration.
Read MoreQuick Question November 2025 Result:
353 people responded, sharing insights on the physical challenges that can come with FTD.
Read MoreWhat We Learn From Every Drop: The Power of Biosamples in FTD
Every biosample holds valuable information that brings us closer to earlier diagnosis and effective treatments for FTD.
Read More